METASTATIC HORMONE REFRACTORY PROSTATE CANCER

Clinical trials for METASTATIC HORMONE REFRACTORY PROSTATE CANCER explained in plain language.

Never miss a new study

Get alerted when new METASTATIC HORMONE REFRACTORY PROSTATE CANCER trials appear

Sign up with your email to follow new studies for METASTATIC HORMONE REFRACTORY PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists test Triple-Threat drug cocktail against spreading prostate cancer

Disease control Completed

This early-stage trial tested the safety of combining three different cancer drugs—cabozantinib, abiraterone, and nivolumab—along with standard hormone therapy for men with newly diagnosed advanced prostate cancer that has spread. The main goal was to find a safe dose for future …

Matched conditions: METASTATIC HORMONE REFRACTORY PROSTATE CANCER

Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

METASTATIC HORMONE REFRACTORY PROSTATE CANCER

Get alerted when new METASTATIC HORMONE REFRACTORY PROSTATE CANCER trials appear

Scientists test Triple-Threat drug cocktail against spreading prostate cancer